Earnings call Advanced Enzymes reported Q3 FY25 consolidated revenue of ₹1,691 million, up 5% YoY and 16% QoQ (adjusted growth 5%). EBITDA rose 3% YoY and 30% QoQ to ₹553 million, with margins at 33%.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

On August 8, Advanced Enzyme Technologies reveals figures for Q1. Wall Street analysts expect Advanced Enzyme Technologies will report earnings per share of INR 2.89. Watch Advanced Enzyme ...

Revenue: INR1,845 million, 26% year-on-year growth, 1% decrease quarter-on-quarter. EBITDA: INR601 million, 42% increase year-on-year, 6% increase quarter-on-quarter. EBITDA Margin: 33% for the ...

* Seeks members' nod to approve related party transaction with JC Biotech Private Limited‍ Source text: Further company coverage: Sign up here. Macro Matterscategory Fed's rate cut revives small ...

LONDON--(BUSINESS WIRE)--The lactase enzyme market is expected to grow by USD 131.55 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the ...

Earnings call Advanced Enzymes' Q2 FY25 revenue declined 7% YoY to ₹1,461M due to export slowdown and ₹83M in deferred revenue. EBITDA margin dropped to 29%. Despite H1 softness, management expects ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

On November 2, Advanced Enzyme Technologies will be reporting Q2 earnings. Wall Street analysts expect Advanced Enzyme Technologies will release earnings per share of INR 2.85. Track Advanced Enzyme ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.